Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Arcus Biosciences’s reported figures.
The source filing: Arcus Biosciences’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001724521-26-000044
FAQ
- What is Arcus Biosciences's EBIT?
- Arcus Biosciences (RCUS) reported EBIT of -$96M in Q2 2026.
- How has Arcus Biosciences's EBIT changed year-over-year?
- Arcus Biosciences's EBIT decreased by 1100.0% year-over-year, from -$8M to -$96M.
- What is the long-term trend for Arcus Biosciences's EBIT?
- Over 4 years (2021 to 2025), Arcus Biosciences's EBIT has grown at a 63.5% compound annual growth rate (CAGR), from $54M to -$386M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Arcus Biosciences's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude